by SCIENCE - Delphine Sterlin | Dec 7, 2020 | 2020 News, Publications, Scientific Publications
Abstract Humoral immune responses are typically characterized by primary IgM antibody responses followed by secondary antibody responses associated with immune memory and composed of IgG, IgA, and IgE. Here, we measured acute humoral responses to SARS-CoV-2, including...
by Micheal O'Neil | Oct 15, 2020 | 2020 News
Instrument-Based, Rapid Test Uses Multi-Antigen Approach; Achieves Best-in-Class Sensitivity and Specificity Genalyte, a leading point-of-care diagnostics and analytics company, announced today its SARS-CoV-2 Multi-Antigen Serology Panel has received Emergency Use...
by Editorial | Oct 13, 2020 | 2020 News
Genalyte, a leading point of care diagnostics and analytics company, announced today the appointment of Ashraf Hanna, M.D. Ph.D, as CEO. “The selection of Dr. Hanna as CEO reflects Genalyte’s transition to the next phase of the company’s development and growth. The...
by Oxford Academic - Isabelle Melki | Aug 8, 2020 | 2020 News, Publications, Scientific Publications
Abstract Objectives JDM and juvenile overlap myositis represent heterogeneous subtypes of juvenile idiopathic inflammatory myopathy (JIIM). Chronic evolution can occur in up to 60% of cases, and morbidity/mortality is substantial. We aimed to describe the clinical,...
by Editorial | Jul 15, 2020 | 2020 News
Antibody Testing Efforts Continue to Expand Throughout San Diego With New Site Opening July 15 July 15, 2020 (San Diego, CA) – San Diego-based healthcare analytics and diagnostics company, Genalyte, today announced the opening of a new COVID-19 antibody testing...
by Editorial | Jul 14, 2020 | 2020 News
Company Makes Serology Testing More Widely Available in Houston as Coronavirus Cases Continue to Surge Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, today announced its SARS-CoV-2 Multi-Antigen Serology...
Recent Comments